When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Alopécia androgenética

Last reviewed: 24 Sep 2025
Last updated: 19 May 2023

Summary

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • presença de fatores de risco
  • história familiar de alopécia
  • regressão gradual da linha capilar frontal, central e da coroa (vértice)
  • afinamento difuso da parte central do couro cabeludo com preservação da linha capilar frontotemporal
Todos los datos

Factores de riesgo

  • história familiar de alopécia
  • idade avançada
  • síndrome do ovário policístico nas mulheres
  • etnia branca
  • resistência insulínica
  • câncer de próstata
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • teste de tração do cabelo
  • teste da função tireoidiana
  • ferritina sérica
Todos los datos

Pruebas diagnósticas que deben considerarse

  • Hemograma completo com diferencial
  • perfil metabólico completo
  • fator antinuclear
  • reagina plasmática rápida
  • testosterona livre
  • sulfato de prasterona (DHEA) sérico
  • globulina ligadora de hormônios sexuais
  • dermatoscopia/tricoscopia
  • biópsia do couro cabeludo
Todos los datos

Algoritmo de tratamiento

En curso

homens que optam pelo tratamento conservador

homens que optam pelo tratamento clínico

mulheres que optam pelo tratamento conservador

mulheres que optam pelo tratamento clínico

tratamento clínico malsucedido

Colaboradores

Autores

Carolyn Goh, MD

Associate Clinical Professor

Department of Medicine

Division of Dermatology

UCLA Medical Center

Los Angeles

CA

Divulgaciones

CG has spoken for the International Society of Hair Restoration Surgeons, the American Academy of Dermatology, the Pacific Dermatologic Association, the California Society of Dermatology and Dermatologic Surgery, and has had manuscripts published in a variety of journals. CG has also participated in advisory boards for Pelage Pharmaceuticals and Pfizer, Inc.

Agradecimientos

Dr Carolyn Goh would like to gratefully acknowledge Dr Robert Haber, Dr Christiane Querfeld, and Dr Christopher R. Shea, previous contributors to this topic. RH has an ownership interest in a company that manufactures light-based hair growth devices and receives royalties for the sales of a surgical device used in hair restoration surgery. CQ and CRS declare that they have no competing interests.

Revisores por pares

Marcelo G. Horenstein, MD

Director of Dermatopathology

The Dermatology Group

Verona

NJ

Divulgaciones

MGH declares that he has no competing interests.

Alvin R. Solomon, MD

Professor of Dermatology

Emory University School of Medicine

Atlanta

GA

Divulgaciones

ARS declares that he has no competing interests.

David Whiting, MD, FACP

Medical Director

The Baylor Hair and Skin Research and Treatment Center

Dallas

TX

Divulgaciones

DW is an author of a number of references cited in this topic. We have since been made aware that Dr David Whiting is deceased.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Starace M, Orlando G, Alessandrini A, et al. Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020 Feb;21(1):69-84. Resumen

European Dermatology Forum. S3 - European Dermatology Forum guideline for the treatment of androgenetic alopecia in women and in men. 2017 [internet publication].Texto completo

Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005 Feb;52(2):301-11. Resumen

Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007 Nov;57(5):767-74. Resumen

Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578-89. Resumen

Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004 Apr;50(4):541-53. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Alopécia androgenética images
  • Diferenciales

    • Alopécia areata difusa
    • Eflúvio telógeno agudo
    • Eflúvio telógeno crônico
    Más Diferenciales
  • Guías de práctica clínica

    • S3 - European dermatology forum guideline for the treatment of androgenetic alopecia in women and in men
    • Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad